209 related articles for article (PubMed ID: 27189275)
61. Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experience.
Jiang F; Jin T; Feng XL; Jin QF; Chen XZ
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C179-84. PubMed ID: 26506872
[TBL] [Abstract][Full Text] [Related]
62. Evaluation of overall survival of nasopharyngeal carcinoma patients treated in ten years at a single institution.
Gokce T; Unlu I; Akcay C
J BUON; 2010; 15(1):36-42. PubMed ID: 20414925
[TBL] [Abstract][Full Text] [Related]
63. Image-based Multilevel Subdivision of M1 Category in TNM Staging System for Metastatic Nasopharyngeal Carcinoma.
Shen L; Li W; Wang S; Xie G; Zeng Q; Chen C; Shi F; Zhang Y; Wu M; Shu W; Pan C; Xia Y; Wu P
Radiology; 2016 Sep; 280(3):805-14. PubMed ID: 27023116
[TBL] [Abstract][Full Text] [Related]
64. Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
Zhang Y; Li WF; Chen L; Mao YP; Guo R; Zhang F; Peng H; Liu LZ; Li L; Liu Q; Ma J
Sci Rep; 2015 Sep; 5():13919. PubMed ID: 26345410
[TBL] [Abstract][Full Text] [Related]
65. Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.
Zeng L; Sun XM; Chen CY; Han F; Huang Y; Xiao WW; Liu S; Tian YM; Deng XW; Lu TX
Head Neck; 2014 May; 36(5):687-93. PubMed ID: 23606573
[TBL] [Abstract][Full Text] [Related]
66. Treatment results of 59 young patients with nasopharyngeal carcinoma.
Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
[TBL] [Abstract][Full Text] [Related]
67. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
[TBL] [Abstract][Full Text] [Related]
68. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of scoring systems and prognostic factors in patients with spinal metastases from nasopharyngeal carcinoma.
Kumar N; Tan JJ; Zaw AS; Lim JL; Wai KL; Malhotra R; Loh TK; Liu GK; Thambiah J
Spine J; 2014 Dec; 14(12):2946-53. PubMed ID: 24912121
[TBL] [Abstract][Full Text] [Related]
70. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
[TBL] [Abstract][Full Text] [Related]
71. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
[TBL] [Abstract][Full Text] [Related]
72. Prognostic factors and long-term outcomes of nasopharyngeal carcinoma in children and adolescents.
Hu S; Xu X; Xu J; Xu Q; Liu S
Pediatr Blood Cancer; 2013 Jul; 60(7):1122-7. PubMed ID: 23303571
[TBL] [Abstract][Full Text] [Related]
73. Development and validation of a magnetic resonance imaging-based model for the prediction of distant metastasis before initial treatment of nasopharyngeal carcinoma: A retrospective cohort study.
Zhang L; Dong D; Li H; Tian J; Ouyang F; Mo X; Zhang B; Luo X; Lian Z; Pei S; Dong Y; Huang W; Liang C; Liu J; Zhang S
EBioMedicine; 2019 Feb; 40():327-335. PubMed ID: 30642750
[TBL] [Abstract][Full Text] [Related]
74. Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma.
Jin Y; Yuan MQ; Chen JQ; Zhang YP
Clinics (Sao Paulo); 2015 Apr; 70(4):264-72. PubMed ID: 26017793
[TBL] [Abstract][Full Text] [Related]
75. Clinical and prognostic analysis in 32 pediatric nasopharyngeal carcinoma.
Chen J; Hu F
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C226-9. PubMed ID: 26506882
[TBL] [Abstract][Full Text] [Related]
76. Survival Prognostication in Patients with Skeletal Metastases from Nasopharyngeal Carcinoma: An Evaluation of the Scandinavian Sarcoma Group, Katagiri and Bauer Scoring Systems.
Tan JJ; Zaw AS; Malhotra R; Wai KL; Tan JY; Kumar N
Ann Acad Med Singap; 2016 Feb; 45(2):51-60. PubMed ID: 27125346
[TBL] [Abstract][Full Text] [Related]
77. Solitary sternal metastasis of nasopharyngeal carcinoma: a case report.
Akbas T; Ugurluer G; Arpaci T
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1947-50. PubMed ID: 23242721
[TBL] [Abstract][Full Text] [Related]
78. Prognosticators and risk grouping in patients with lung metastasis from nasopharyngeal carcinoma: a more accurate and appropriate assessment of prognosis.
Cao X; Luo RZ; He LR; Li Y; Lin WQ; Chen YF; Wen ZS
Radiat Oncol; 2011 Aug; 6():104. PubMed ID: 21871101
[TBL] [Abstract][Full Text] [Related]
79. [Clinicopathological features and prognosis of patients in endometrial cancer with bone metastases].
Jiang F; Ren T; Cheng NH; Cao DY; Yang JX; Wu M; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2019 Jul; 54(7):452-457. PubMed ID: 31365957
[No Abstract] [Full Text] [Related]
80. Five-year survival and median survival time of nasopharyngeal carcinoma in Hospital Universiti Sains Malaysia.
Siti-Azrin AH; Norsa'adah B; Naing NN
Asian Pac J Cancer Prev; 2014; 15(15):6455-9. PubMed ID: 25124642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
